BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34273359)

  • 1. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis.
    Andrianto ; Al-Farabi MJ; Nugraha RA; Marsudi BA; Azmi Y
    Microvasc Res; 2021 Nov; 138():104224. PubMed ID: 34273359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: A systematic review and meta-analysis.
    Mohebbi A; Haybar H; Nakhaei Moghaddam F; Rasti Z; Vahid MA; Saki N
    Rev Med Virol; 2023 Jul; 33(4):e2442. PubMed ID: 36943015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfuntion in children with idiopathic nephrotic syndrome.
    Sharma B; Saha A; Dubey NK; Kapoor K; Anubhuti ; Batra VV; Upadhayay AD
    Atherosclerosis; 2014 Apr; 233(2):704-706. PubMed ID: 24583419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
    Leurs PB; Stolk RP; Hamulyak K; Van Oerle R; Grobbee DE; Wolffenbuttel BH
    Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator.
    Takahashi H; Ito S; Hanano M; Wada K; Niwano H; Seki Y; Shibata A
    Am J Hematol; 1992 Sep; 41(1):32-9. PubMed ID: 1323930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins.
    Bombeli T; Jutzi M; De Conno E; Seifert B; Fehr J
    Blood Coagul Fibrinolysis; 2002 Oct; 13(7):577-81. PubMed ID: 12439142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
    Fernández S; Moreno-Castaño AB; Palomo M; Martinez-Sanchez J; Torramadé-Moix S; Téllez A; Ventosa H; Seguí F; Escolar G; Carreras E; Nicolás JM; Richardson E; García-Bernal D; Carlo-Stella C; Moraleda JM; Richardson PG; Díaz-Ricart M; Castro P
    Shock; 2022 Jan; 57(1):95-105. PubMed ID: 34172614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
    Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
    Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis.
    Lampsas S; Tsaplaris P; Pantelidis P; Oikonomou E; Marinos G; Charalambous G; Souvaliotis N; Mystakidi VC; Goliopoulou A; Katsianos E; Siasos G; Vavuranakis MA; Tsioufis C; Vavuranakis M; Tousoulis D
    Curr Med Chem; 2022; 29(21):3790-3805. PubMed ID: 34702152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation and endothelial perturbation parallel COVID-19 severity and activity.
    Cugno M; Meroni PL; Gualtierotti R; Griffini S; Grovetti E; Torri A; Lonati P; Grossi C; Borghi MO; Novembrino C; Boscolo M; Uceda Renteria SC; Valenti L; Lamorte G; Manunta M; Prati D; Pesenti A; Blasi F; Costantino G; Gori A; Bandera A; Tedesco F; Peyvandi F
    J Autoimmun; 2021 Jan; 116():102560. PubMed ID: 33139116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity.
    Li Y; Chen H; Tan J; Wang X; Liang H; Sun X
    Eur J Clin Invest; 1998 Dec; 28(12):1050-4. PubMed ID: 9893018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis.
    Takagi M; Wada H; Mukai K; Kihira H; Yano S; Minamikawa K; Wakita Y; Nakase T; Nagaya S; Deguchi K
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):713-7. PubMed ID: 7865676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
    Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
    Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Illingworth K; Blann A; Hay CR; Hollis S; Jayson MI
    Ann Rheum Dis; 1996 Feb; 55(2):122-7. PubMed ID: 8712862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
    Norooznezhad AH; Mansouri K
    Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection.
    Sosothikul D; Seksarn P; Pongsewalak S; Thisyakorn U; Lusher J
    Thromb Haemost; 2007 Apr; 97(4):627-34. PubMed ID: 17393026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
    Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A
    Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.